ENVB
NASDAQ · Pharmaceuticals
Enveric Biosciences Inc
$1.95
-0.05 (-2.50%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+408.2% upside
Low Target
$5.56
Average Target
$9.91
High Target
$13.09
Current Price
$1.95
Current
$1.95
$1.95
Target
$9.91
$9.91
$5.56
$9.91 avg
$13.09
Scenario Analysis
Bear Case
$5.56
185.1%
Low target
Base Case
$9.91
+408.2%
Avg target
Bull Case
$13.09
+571.3%
High target
Risk/Reward
3.1x
Highly favorable
Price in Context
52-Week High
$21.60
-91.0% from high
52-Week Low
$1.82
+7.1% from low
Target vs 52W High
$9.91
-54.1% vs high
Next Earnings Report
Mar 26, 2026 · After Market Close
Today
EPS Est: $-0.32
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| LLY | Strong Buy | 39 | 77% | $1,330.33 | +45.2% |
| JNJ | Buy | 32 | 59% | $299.55 | +24.8% |
| MRK | Buy | 36 | 67% | $159.27 | +33.4% |
| PFE | Hold | 35 | 40% | $33.90 | +24.3% |
| BMY | Hold | 36 | 42% | $174.50 | +196.1% |
| ZTS | Buy | 25 | 64% | $209.87 | +79.8% |
| RPRX | Strong Buy | 16 | 88% | $36.26 | -22.9% |
| VTRS | Buy | 18 | 67% | $122.82 | +809.8% |